ArticleEClinicalMedicine2022

Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study.

Christopher M Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.